Search results
Results from the WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
[39] [43] She also completed a summer internship at the Federal Trade Commission, worked as a tour guide at the Bureau of Engraving and Printing, and participated in anti-apartheid protests at the South African embassy and National Mall. [41] [44] [45] [34] Harris graduated in 1986 with a degree in political science and economics. [46]
October 4, 2024 at 2:31 PM. GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report. The U.S. government has granted $72 million to European pharma giants GSK ...
[17] [18] Season 1 was announced along with a release date of July 2, 2024 in the Ubisoft Forward 2024 event. Content included three maps, with one map coming out per month, three new weapons, a new faction (GSK from Rainbow Six: Siege), Capture the Flag mode, ranked progression rewards, and more in-store items and bundles. The studio also ...
Citing the U.S. agency's decision, GSK cut its forecast for 2024 vaccine sales. It now expects that business to grow by a low to mid-single digit percentage, from an earlier expectation of high ...
(Reuters) -GSK CEO Emma Walmsley's total remuneration rose 51% to 12.7 million pounds ($16 million) in 2023, thanks to a big jump in performance-related pay, the British drugmaker's annual report ...
Rotarix (human rotavirus vaccine, live attenuated) Shingrix (for Zoster Vaccine Recombinant, Adjuvanted) Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed)) Twinrix (for combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)) Typherix (typhoid vaccine (purified polysaccharide ...
GSK on Wednesday raised its full-year profit and sales forecasts for a second time, after better-than-expected quarterly sales of its newly-launched respiratory syncytial virus (RSV) vaccine ...